Clinical Trial to Evaluate the Safety and Effectiveness of TQB2618 Injection Combined Therapy in Patients With Advanced Esophageal Squamous Cell Carcinoma

Stopped This study was closed due to business reasons. Closure was not prompted by any safety or efficacy concerns.

Conditions

• Advanced Esophageal Squamous Cell Carcinoma

Interventions

• DRUG: TQB2618 injection, Penpulimab injection, Paclitaxel, Cisplatin
• DRUG: Penpulimab injection, Paclitaxel, Cisplatin
• DRUG: TQB2618 injection, Penpulimab injection, TQB3617capsules

Sponsor

Chia Tai Tianqing Pharmaceutical Group Co., Ltd.